Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy (Q79328017)
Jump to navigation
Jump to search
scientific article published on 01 December 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy |
scientific article published on 01 December 2006 |
Statements
Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy (English)
Ingrid U Scott
Léssia P Cintra
1 December 2006